A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
Lontos K, Tsagianni A, Agha M, Raptis A, Hou JZ, Farah R, Redner RL, Im A, Dorritie KA, Sehgal A, Rossetti J, Aggarwal N, Saul M, Gooding W, Boyiadzis M.
Lontos K, et al. Among authors: sehgal a.
Leuk Lymphoma. 2022 Dec;63(13):3257-3260. doi: 10.1080/10428194.2022.2118532. Epub 2022 Sep 8.
Leuk Lymphoma. 2022.
PMID: 36075047
Free PMC article.
No abstract available.